Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
INBX
MAZE
Add up to 3 more stocks
INBX
Inhibrx Biosciences Inc.
+1.58%
$96.05+1.49Delayed quote: Oct 6, 2026, 11:49 AM EDT
Market Cap
$1.41B
52W Range
$28.16 - $155.29
MAZE
Maze Therapeutics, Inc.
+0.23%
$26.49+0.06Delayed quote: Oct 6, 2026, 11:50 AM EDT
Market Cap
$1.47B
52W Range
$21.95 - $53.65
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 3.24 |
| P/S Ratio | N/A | 73.30 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -91.0% | 0.0% |
| Operating Margin | -10386.5% | 0.0% |
| Net Margin | -10773.5% | -668.0% |
| ROE | N/A | -29.5% |
| ROA | -89.6% | -25.1% |
| ROIC | -99.3% | -28.6% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.07 | 18.31 |
| Quick Ratio | 5.07 | 18.31 |
| Debt/Equity | N/A | 0.13 |
| Interest Coverage | -11.07 | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.